Ma Kuang Healthcare Holding (4139) Fair Value & Analysis
Healthcare · TW · Market cap 1.1B TWD
Fair value as of: Jun 25, 2026
Analysis
Ma Kuang Healthcare Holding (4139) currently trades at 24.75 TWD, while our model-based Fair Value estimate is 50.82 TWD — implying the stock looks roughly 105.3% undervalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Ma Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan, Singapore, Mainland China, and internationally. The company offers community medical services, Chinese medical services, Chinese medicines, medical management training courses, educational support services, etc. It also provides medical treatment, and overseas student homestay and guardianship services; management consultant services; Chinese medicine beauty services; consulting services, such as corporate management, computer technology, industry information, and marketing; and e-commerce sales services. In addition, the company operates clinics, educational institutions, community medicine clinics, and traditional Chinese medicine clinics. Further, it is involved in sale of dietary supplement, and pharmaceutical and medical goods in stores; restaurant business; and leasing and other services. The company was incorporated in 2009 and is based in Kaohsiung, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Ma Kuang Healthcare Holding (4139) undervalued?
What is the fair value of 4139?
What is the quality score of 4139?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.